MoneyWorks4Me

A fair growth of 24.56% in the revenue at Rs. 1736.10 millions was reported in the March 2025 quarter as compared to Rs. 1393.80 millions during year-ago period.Profit saw a slight increase of 23.78%to Rs. 865.00  millions from Rs. 698.80 millions.OP of the company witnessed a marginal growth to 1162.90 millions from 938.60 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 1736.10 1393.80 24.56 7524.10 6250.90 20.37 7524.10 6250.90 20.37
Other Income 412.50 361.80 14.01 1345.90 1058.40 27.16 1345.90 1058.40 27.16
PBIDT 1162.90 938.60 23.90 4665.60 3929.20 18.74 4665.60 3929.20 18.74
Interest 0.40 0.20 100.00 1.20 1.00 20.00 1.20 1.00 20.00
PBDT 1162.50 938.40 23.88 4664.40 3928.20 18.74 4664.40 3928.20 18.74
Depreciation 60.90 69.30 -12.12 247.70 270.80 -8.53 247.70 270.80 -8.53
PBT 1101.60 869.10 26.75 4416.70 3657.40 20.76 4416.70 3657.40 20.76
TAX 236.60 170.30 38.93 1021.80 820.30 24.56 1021.80 820.30 24.56
Deferred Tax 0.30 -1.90 -115.79 -7.20 -40.90 -82.40 -7.20 -40.90 -82.40
PAT 865.00 698.80 23.78 3394.90 2837.10 19.66 3394.90 2837.10 19.66
Equity 152.00 151.90 0.07 152.00 151.90 0.07 152.00 151.90 0.07
PBIDTM(%) 66.98 67.34 -0.53 62.01 62.86 -1.35 62.01 62.86 -1.35
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..